IDIBELL on the media
SpadaHC, a new database to improve hereditary cancer genes variants classification in the Spanish population
The tool, developed by IDIBELL, ICO and CIBERONC researchers, facilitates a more precise and uniform genetic variants classification, a key to making clinical decisions in patients with suspected cancer and to improving attention to patients and their families
Bellvitge co-leads an international trial that can change the treatment of heart failure
Published in the New England Journal of Medicine, this trial has confirmed the benefits of a drug, finerenone, in an important segment of heart failure cases. The study included more than 6,000 patients from 50 countries and, in Spain it has been coordinated by IDIBELL and Bellvitge Hospital.
Researchers describe a cellular map of the pancreas that will help design better treatments against pancreatic cancer and diabetes
Researchers from IDIBELL and the UB create a cell-by-cell map of the pancreas ducts and identify 15 new cell populations in the pancreas. THe results will provide a better understanding of how pancreatic cancer develops and will help find treatments for diabetes.
Bellvitge researchers evaluate the use of multiplex real-time PCR in pneumonia to reduce the use of antibiotics
According to the study published in Nature Communications, the use of multiple quantitative PCR increased etiological diagnoses and reduced the time needed to achieve them, decreasing too the time to conversion from intravenous to oral treatment, although no reduction in antibiotic consumption was observed.
We all know a mother, that’s for her: a solidary wedding raises funds for breast cancer research
The donation made by the bride and groom and the guests will help fund the research led by Dr. Sonia Pernas, researcher at IDIBELL and ICO
Researchers identify a new prognostic biomarker of relapse in cutaneous squamous cell carcinoma and the mechanisms responsible for tumor progression
The study, which has been published in the scientific journal ‘Journal of Experimental & Clinical Cancer Research’, shows that the ITGAV protein allows a better stratification of patients and reveals new therapeutic avenues for this carcinoma.
IDIBELL’s scientific and technical services incorporate a new spatial transcriptomics and proteomics platform
The purchase of the equipment has been financed by the Carlos III Health Institute (IFEQ22 call).
A new genomic study analyzes antibiotic resistance in two species of pathogenic bacteria
The research carried out by IDIBELL and Bellvitge University Hospital has found a higher level of antibiotic resistance in parainfluenzae than H. influenzae.
